IAG Wealth Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
IAG Wealth Partners's PFE Position: Q1 2026 in Review
IAG Wealth Partners increased its Pfizer (PFE) stake by 0.79% in Q1 2026, buying an estimated $266 and bringing the position to 1,271 shares worth $35.7K. The position accounts for ﹤0.01% of the portfolio, ranked #240.
IAG Wealth Partners first reported a position in PFE in Q4 2019 and has held it in 25 quarters since. The position peaked at $228K in Q1 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- IAG Wealth Partners held 1,271 shares of Pfizer worth $35.7K as of Q1 2026.
- IAG Wealth Partners bought 10 Pfizer shares in Q1 2026, an estimated $266.
- Pfizer made up ﹤0.01% of IAG Wealth Partners's portfolio in Q1 2026, its #240 holding.
- IAG Wealth Partners first reported a position in Pfizer in Q4 2019 and has held it in 25 quarters since.
- IAG Wealth Partners's Pfizer position peaked at $228K in Q1 2025.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on IAG Wealth Partners's 13F filing for Q1 2026, filed 29 Apr 2026.